Health In Tech, Inc.

Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Health in Tech third quarter of 2025 earnings conference call. Currently, all participants are in listen-only mode. Later, we will conduct a question and answer session, and instructions will follow at that time. As a reminder, we are recording today's call. If you have any objections, you may disconnect at this time. Now, I will turn the call over to Lori Babcock, Chief of Staff for the company. Ms. Babcock, please proceed.

Thank you, operator, and hello, everyone. Welcome to the Health and Tech's third quarter of 2025 earnings conference call. Joining us today are Mr. Tim Johnson, Chief Executive Officer, Mr. Dustin Plantholt, Chief AI and Marketing Officer, and Ms. Julia Chen, Chief Financial Officer. Full details of our results can be found in our earnings press release and in our related form 10-Q to be filed with the SEC. These documents will be available on our investor relations website at healthintech.investorroom.com. As a reminder, today's call is being recorded and a replay will be available on our IR website as well. Before we continue, please note that today's discussion includes forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based on information available as of today and involve risks, uncertainties, and assumptions that could cause actual results to differ materially from those expressed or implied, including those discussed in our quarterly report on Form 10-Q for the period ended September 30, 2025, to be filed with the SEC. Please review the forward-looking and cautionary statement section at the end of our earnings release for various factors that could cause actual results to differ materially from forward-looking statements made during our call today. We undertake the obligation to update and expressly disclaim the obligation to update these forward-looking statements to reflect events or circumstances after the date of this call or to reflect new information of the occurrence of unanticipated events. We may also refer to certain financial measures not in accordance with generally accepted accounting principles such as adjusted EBITDA for comparison purpose only. Our GAAP results and reconciliations of GAAP to non-GAAP measures can be found in our earnings press release. With that, I now turn the call over to our CEO, Mr. Tim Johnson. Tim?

Thank you and good afternoon, everyone. I appreciate you joining us today. I'm pleased to share our third quarter results, which were well aligned with our expectations as we continue to invest in strategic channel partners and rapidly expand our distribution network. At a high level, we delivered another quarter of strong revenue growth. Revenue reached $8.5 million, up from 90% year over year, bringing nine-month revenue to $25.8 million compared to $19.5 million for the full year of 2024. This momentum was driven by the continued expansion of our sales distribution network. The number of brokers, TPAs, and agencies grew to 849 partners, up 57% year over year. As more brokers and agencies adopt our EDIBs platform, we're seeing more quotes bound and sold in real time. By the end of the third quarter, the number of BILD enrolled employees reached 25,248, an increase of 7,654 employees year over year. The third quarter is typically a development and deployment period for us, a time to introduce new programs and features. Most notably, we completed beta testing and officially launched the large employer underwriting capability with our enhanced eDIBS platform. This is a major milestone that scales our reach across the full employer spectrum, positioning health and tech as a true insurance marketplace for business of all sizes. The new capability enables brokers to generate fully bindable quotes for groups of 150 more employees in as little as two weeks compared to the industry norm of about three months. This advancement dramatically expands our addressable market and establishes health and tech among the few platforms serving both small and large employers seamlessly. Soon after the launch, we showcased this innovation at the SIIA National Conference in October 2025, one of the most influential events in the self-insurance industry. Our participation there helped accelerate national exposure and strengthen broker relationships. key catalyst for future growth. As we look to the fourth quarter and into Q1 2026, we're entering our peak enrollment period when employers review or switch their health care coverage. Recent market uncertainty and rising health care costs have created mixed timing patterns, with some employers making early plan selections in late Q3, while others are delaying decisions into January. As a result, we delivered much better year-over-year growth in Q3 and anticipating sales volume shift from Q4 into Q1, but still expect healthy year-over-year overall growth. To help employers navigate cost volatility, we're testing a new program offering a three-year rate hold, a solution that provides predictable, stable pricing over a multi-year period. The program allows groups with 150 or more employees to lock in healthcare costs for three years through a fixed remittance model backed by an A-rated stop-loss carrier. It brings real time, excuse me, real value to clients looking for cost stability amid rising medical expenses while also strengthening our relationships with brokers and TPAs. By providing cost certainty amid rising medical expenses, We're giving brokers and TPAs powerful retention tools and helping employers plan long-term with greater confidence. We completed initial testing in October and plan to fully launch the program in the first quarter of 2026. We believe it represents an innovative concept for broader healthcare insurance market, and we're optimistic about its reception as we enter 2026. Beyond underwriting innovation, we're setting our sights on one of the largest inefficiencies in U.S. healthcare, claims processing, which consumes more than $300 billion annually in administrative costs and delays. This quarter, we announced a non-binding letter of intent with AlphaTon Capital Corp. to co-develop HitChain, a blockchain-enabled platform designed to bring real-time visibility, accuracy, and accountability to claims workflows across the ecosystem. Under this LOI, both companies plan to contribute distinct strengths. Health & Tech brings domain expertise in insurance and healthcare data standards, established broker and carrier relationships, proven go-to-market channels, and leadership in health technology design. AlphaTen Capital contributes blockchain development expertise on the open network, smart contract architecture, cybersecurity, stable coin integration for secure payments, and capital resources for enterprise-scale deployment. Together with AlphaTon's blockchain infrastructure and Brittany Kaiser's leadership and data ethics, we are building HitChain, a decentralized and verifiable claims system aimed at compressing timelines, eliminating duplication, reducing costs and creating a transparent system of record for payers and providers alike. By combining insurance domain expertise with blockchain innovation, Health & Tech is positioned at the forefront of decentralized healthcare insurance technology infrastructure, a market opportunity of meaningful scale and long-term impact. Lastly, we're thrilled to share that Health & Tech will host the InsureTech Summit at Davos during the World Economic Forum week in January, 2026. This event will convene global leaders to discuss AI technology and transformation of critical business sectors, including healthcare and insurance. With that, I will now turn it over to Dustin, who will walk through our latest marketing and partnership innovations in greater detail. Dustin.